Cargando…

APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer

Lung cancer is the leading cause of cancer-associated mortality. Non-small cell lung cancer (NSCLC) accounts for >80% of lung cancers. The overall survival for NSCLC is dismal, with a 5-year survival of <5% for patients. Thus, identifying an effective biomarker for early diagnosis of lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Hengli, Yan, Zhaohua, Zhang, Meng, Xu, Xiaoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103951/ https://www.ncbi.nlm.nih.gov/pubmed/27900003 http://dx.doi.org/10.3892/ol.2016.5095

Ejemplares similares

APRIL promotes non-small cell lung cancer growth and metastasis by targeting ERK1/2 signaling
por: Dou, Hengli, et al.
Publicado: (2017)

The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2020)

BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis
por: Pelekanou, Vassiliki, et al.
Publicado: (2013)

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma
por: Larson, Rebecca C., et al.
Publicado: (2023)

Expression of TNF-α, April and BCMA in Behcet's Disease
por: Shaker, Olfat G., et al.
Publicado: (2014)

APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis
por: Lendak, Dajana F., et al.
Publicado: (2018)

No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells
por: Nys, Josquin, et al.
Publicado: (2013)

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
por: Nelke, Johannes, et al.
Publicado: (2020)

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
por: Tai, Yu-Tzu, et al.
Publicado: (2018)

Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long Glycosaminoglycans
por: Marcisz, Mateusz, et al.
Publicado: (2021)

TACI Expression and Signaling in Chronic Lymphocytic Leukemia
por: Mamara, Antigoni, et al.
Publicado: (2015)

Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules
por: Jasek, Monika, et al.
Publicado: (2020)

BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
por: Pelekanou, Vasiliki, et al.
Publicado: (2018)

Effect of TACI Signaling on Humoral Immunity and Autoimmune Diseases
por: Zhang, Yi, et al.
Publicado: (2015)

TACI Isoforms Regulate Ligand Binding and Receptor Function
por: Garcia-Carmona, Yolanda, et al.
Publicado: (2018)

Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
por: Hinterleitner, Clemens, et al.
Publicado: (2021)

TACI and BAFF-R mediate isotype switching in B cells
por: Castigli, Emanuela, et al.
Publicado: (2005)

TACI Constrains T(H)17 Pathogenicity and Protects against Gut Inflammation
por: Tan, Andy Hee-Meng, et al.
Publicado: (2020)

Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization
por: Camviel, Nicolas, et al.
Publicado: (2022)

Corrigendum: TACI Isoforms Regulate Ligand Binding and Receptor Function
por: Garcia-Carmona, Yolanda, et al.
Publicado: (2019)

TACI expression and plasma cell differentiation are impaired in the absence of functional IκBNS
por: Khoenkhoen, Sharesta, et al.
Publicado: (2019)

Heterozygous Alterations of TNFRSF13B/TACI in Tonsillar Hypertrophy and Sarcoidosis
por: Speletas, Matthaios, et al.
Publicado: (2013)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
por: Kakkas, Ioannis, et al.
Publicado: (2021)

Transmembrane Activator and CAML Interactor (TACI): Another Potential Target for Immunotherapy of Multiple Myeloma?
por: Xu, Shengli, et al.
Publicado: (2020)

Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report
por: Li, Dan, et al.
Publicado: (2022)

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

Rare TACI Mutation in a 3-Year-Old Boy With CVID Phenotype
por: Leonardi, Lucia, et al.
Publicado: (2019)

TACI triggers immunoglobulin class switching by activating B cells through the adaptor protein MyD88
por: He, Bing, et al.
Publicado: (2010)

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers
por: Mizutani, Hironori, et al.
Publicado: (2018)

PB2052: THE HEMATOLOGICAL SIDE OF TNFRSF13B/TACI: A MONOCENTRIC EXPERIENCE
por: Beccaria, Andrea, et al.
Publicado: (2023)

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
por: Cho, Shih-Feng, et al.
Publicado: (2018)

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
por: Seipel, Katja, et al.
Publicado: (2022)

BCMA-targeted immunotherapy for multiple myeloma
por: Yu, Bo, et al.
Publicado: (2020)

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells
por: Sintes, Jordi, et al.
Publicado: (2017)

TACI-Deficient Macrophages Protect Mice Against Metaflammation and Obesity-Induced Dysregulation of Glucose Homeostasis
por: Liu, Lunhua, et al.
Publicado: (2018)

PB1855: LACK OF MUTATIONS IN TNFRSF13B (TACI) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: Giannakoulas, N., et al.
Publicado: (2022)

Prognostic role of multiple abnormal genes in non-small-cell lung cancer
por: Yan, Lu-Da, et al.
Publicado: (2022)

Anti-BCMA novel therapies for multiple myeloma
por: Sammartano, Vincenzo, et al.
Publicado: (2023)

Teclistamab impairs detection of BCMA CAR-T cells
por: Glatte, Bettina, et al.
Publicado: (2023)

The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells
por: Saulep-Easton, Damien, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pvq3fsujdhevitda5ggsbord0g